Production

1.JPG

Production resources

The plant is located in an area of 17 hectares and has all required sites for the operation of primary and auxiliary production units as well as reserved areas for future expansion. The site is equipped with all necessary transportation and power supply utilities, its own boiler station and well site.

Our technologies

Our research laboratory is equipped with all the required state-of-the-art testing facilities and is rightfully considered the best in Kazakhstan. Today the plant is a leader among local pharmaceutical manufacturers. Our company is producing not only for the internal market but is also exporting its products to far-and-near countries abroad.

Nowadays, the plant produces more than 113 items of generic drugs available in the form of sterile antibiotic powders capsules, injection solutions in ampoules, infusion solutions, tablets, capsules, powders in sachets, syrups.

Full production cycle is accompanied with automated testing and is certified by a microbiological purity system. The quality of the final products is controlled by in-house laboratory which is equipped with advanced analytical technology.

The plant’s high quality products are provided due to the:

  • Highly-qualified and responsible personnel;

  • Qualified and validated production processes;

  • Modern high-tech equipment of European manufacturers: IMA, Marcesini (Italy), Telstar (Spain), Bosch (Germany), Romelag (Switzerland) etc;

  • Strict quality control at all production stages in conformity with international standards;

  • The use of the majority of medicinal substances from European manufacturers in the manufacturing process of medical products.

3.JPG  5.jpg

The generic drugs that are produced by the Company are totally comparable in composition and affect with their original dosage form. Technologically advanced testing methods allow for the elimination of even the tiniest deviations in composition and therapeutic properties that might occur between products and their original dosage form.

The production volumes of finished dosage forms are increasing at a high rate. Every year our portfolio is enlarged due to new preparations for a wide and directed range of therapeutic actions. New technologies are adopted, new productions are started, and the infrastructure is updated. All of this enables us to research, develop, and produce safe and effective high quality drugs at affordable prices that improve the quality of life and help people to be healthy, feel better, do more, and live longer.

State license No.6591163DX from 05.09.2014, general, issued by: Department of Health of South Kazakhstan Region, Akimat of South Kazakhstan Region.

4.jpg